Meda AB
 | |
| File:Meda AB logo.svg | |
| OTCPK:MDABY | |
| Headquarters | , Sweden |
| Revenue | >kr 15,000,000,000 (2014) |
Number of employees | 5,202 (2014) |
| Parent | Mylan  |
Meda AB is a specialty pharmaceutical company, headquartered in Solna, Sweden. At the end of 2014, Meda had 5,202 employees. Meda's pharmaceuticals are sold in more than 150 countries.[1]
Meda was listed on the Stockholm stock market until it was acquired by Mylan in 2016 through a cash and stock offer.
Mergers, acquisitions and divestments
In 2014, Meda acquired the Italian firm RottaPharm Madaus in order to add consumer health products to their portfolio.[2] Meda explored in 2015 the possibility of divesting its United States division, Meda Pharmaceuticals, to raise funds for expansion in other areas.[2]
| Meda |
| |||||||||
References
- ^ "About Meda". Meda AB. Retrieved 15 August 2015.[self-published source]
- ^ a b Ewing, Adam; Baigorri, Manuel (27 August 2015). "Swedish Drugmaker Meda Said to Weigh Sale of U.S. Operations". Bloomberg Business. Retrieved 28 August 2015.